Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of TNNT1-Myopathy With L-Tyrosine. A Double-blind, Placebo-controlled Crossover Trial.

NCT02035501 is registered in ClinicalTrials.gov with Hadassah Medical Organization as lead sponsor.

NCT NCT02035501
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02035501 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of TNNT1-Myopathy With L-Tyrosine. A Double-blind, Placebo-controlled Crossover Trial.
Lead sponsor
Hadassah Medical Organization
Phase
Phase 2
Overall status
Unknown status
Start date
January 31, 2014
Completion date
Not reported
Enrollment
10 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

nemaline myopathy